Acutaas Chemicals Share Price Today

Acutaas shareholders reject ESOP scheme for subsidiary employees at AGM

Shareholders rejected the ESOP scheme for subsidiary employees with 72.63% votes in favour, below the 75% threshold. Institutional investors cast 57.67% of their votes against the ESOP proposal, driving the rejection. All other resolutions, including financial statements, dividend, and director reappointments, passed with over 97% support. Final dividend for FY26 was approved with 99.9998% of votes in favour.

Acutaas Chemicals approves acquisition of step-down subsidiary Enchem Ami Organics

Acutaas Chemicals approved acquiring 100% of Enchem Ami Organics Private Limited. Acquisition cost totals ₹1,00,000 at face value of ₹10 per share. EAOPL becomes a direct wholly owned subsidiary from step-down status. Target entity reports nil turnover for FY25 and FY26. Transaction completed via cash consideration within one month.

Acutaas Chemicals to host investor meet at PL Capital conference on Sep 28

Acutaas Chemicals to attend PL Capital Mid & Small Cap Conference on September 28, 2026. Meetings scheduled for one-on-one and group interactions in Mumbai. Company confirms no unpublished price-sensitive information will be shared. Disclosure made under SEBI Listing Regulations to BSE and NSE.

Acutaas Chemicals granted process patent for 2,4-dimethylthiophenol

Patent granted for 2,4-dimethylthiophenol preparation process. Total patents held by company now stand at 11. Patent term is 20 years from filing date in 2017. Disclosure made under SEBI LODR Regulation 30.

Acutaas Chemicals inaugurates HPAPI pilot plant in Surat for R&D

Acutaas Chemicals inaugurated a new pilot plant at Unit 1, Sachin, Surat on September 4, 2026. The facility features OEB 4 containment for handling highly potent API intermediates. It supports R&D for new product trials and process scale-up validation. The expansion targets high-potency APIs used in targeted therapies like oncology.

Acutaas Chemicals convenes AGM for dividend and RPT approvals

Acutaas Chemicals convenes 19th AGM on September 24, 2026, to approve FY26 final dividend of ₹2.50 per share. Shareholders to ratify related party transactions with subsidiary ACEPL up to ₹2,900 million. Board seeks approval for loans/guarantees to ACEPL up to ₹1,000 million outstanding. Re-appointment of directors Ram Mohan Lokhande and Anita Bandyopadhyay for five-year terms.